A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
Clinical trial NCT01458275 · COMPLETED
Trial details
- NCT number
- NCT01458275
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-03-01
- Enrollment
- 847
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.